Related Experiment Video

Updated: May 31, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

How applicable are clinical practice guidelines to elderly patients with comorbidities?

Donatus R Mutasingwa1, Hong Ge, Ross E G Upshur

  • 1Public Health and Preventive Medicine program, Dalla Lana School of Public Health, University of Toronto, Ontario.

Canadian Family Physician Medecin De Famille Canadien
|July 15, 2011
PubMed

Insights

Most clinical practice guidelines (CPGs) mention older adults but few address the complexities of multiple comorbidities in the elderly. Guideline developers need to improve patient-centered care for this population.

Area of Science:

  • Geriatric Medicine
  • Health Services Research
  • Clinical Practice Guidelines

Background:

  • Clinical practice guidelines (CPGs) are essential tools for evidence-based healthcare.
  • Assessing the applicability of existing CPGs to specific patient populations, such as the elderly with multiple comorbidities, is crucial for effective healthcare delivery.

Purpose of the Study:

  • To evaluate how well 10 common clinical practice guidelines (CPGs) cater to elderly patients managing multiple chronic conditions.

Main Methods:

  • A content analysis was performed on 10 Canadian CPGs covering prevalent chronic diseases.
  • The analysis focused on the presence of key indicators: mention of older adults or those with comorbidities, consideration of life expectancy in treatment benefit timelines, and discussion of implementation barriers.

Main Results:

  • While most CPGs (7/10) mentioned the elderly and a majority (8/10) addressed patients with comorbidities, only a few (4/10) considered life expectancy in treatment benefit.
  • Fewer than half (5/10) discussed implementation barriers, indicating a gap in practical applicability for complex geriatric patients.

Conclusions:

  • Current CPGs often lack sufficient detail to guide the care of elderly individuals with multiple health issues.
  • Enhancing CPGs to be more patient-centered, rather than solely disease-focused, requires explicit inclusion of considerations for elderly patients with comorbidities.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...